Abstract
A UK Stem Cell company has developed a novel product which allows large numbers of small blastomere-like stem cells (BLSCs) to be isolated from whole blood and banked. In order to grow these cells into cell banks suitable for research, diagnostic or clinical use - the company needs to partner with academic/industry with innovative culture media which will allow these cells to proliferate in a rapid manner without differentiation for commercial scale up.
Reference Nr 12 GB 46P4 3PEP


